Arcus Biosciences (RCUS) PT Lowered to $40 at Citi
Tweet
Share
E-mailGet Alerts RCUS Hot Sheet
Price: $29.48 +2.15%
Rating Summary:
12 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
12 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz lowered the price target on Arcus Biosciences (NYSE: RCUS) to $40.00 (from $42.00) while maintaining a Buy rating.
You May Also Be Interested In
- Arcus Biosciences (RCUS) PT Raised to $23 at Morgan Stanley
- Travel Food Services (TRAVELFO:IN) PT Raised to INR1,600 at ICICI Securities
- Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR375 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
